| II-43 Christophe Meille Combining BLRM and safety PKPD models to improve decision making in a phase I dose escalation study: case study of PCA062, an antibody drug conjugate targeting P-Cadherin Wednesday 15:10-16:40 |
| II-43 Christophe Meille Combining BLRM and safety PKPD models to improve decision making in a phase I dose escalation study: case study of PCA062, an antibody drug conjugate targeting P-Cadherin Wednesday 15:10-16:40 |